Jeff Goldberg is the founder of Aeglea BioTherapeutics. Aeglea BioTherapeutics has raised $375M in total funding. Latest round: Growth.
Jeffrey M. Goldberg was appointed president, chief executive officer, and a member of the board of directors of Aeglea BioTherapeutics in November 2022. He is an experienced biotech executive with over 25 years of experience leading teams from preclinical discovery through commercialization.
Full founder directory · Investor directory · Company funding database · Fundraising library